capecitabine has been researched along with Delayed Hypersensitivity in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badrick, TC; Gilbar, PJ; Grewal, GD | 1 |
| Costello, E; Cox, T; Ghaneh, P; Greenhalf, W; Middleton, G; Neoptolemos, JP; Palmer, DH; Shaw, V | 1 |
| Buyukozturk, S; Colakoglu, B; Demir, S; Gelincik, A; Olgac, M; Saglam, S | 1 |
| Aarntzen, EA; Adema, GJ; de Boer, A; de Vries, IJ; Figdor, CG; Lesterhuis, WJ; Preijers, FW; Punt, CJ; Scharenborg, NM; van de Rakt, M; van Spronsen, DJ | 1 |
1 trial(s) available for capecitabine and Delayed Hypersensitivity
| Article | Year |
|---|---|
Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; C-Reactive Protein; CA-19-9 Antigen; Cancer Vaccines; Capecitabine; Carcinoma, Pancreatic Ductal; Cell Proliferation; Deoxycytidine; Female; Gemcitabine; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hypersensitivity, Delayed; Interleukin-6; Male; Middle Aged; Pancreatic Neoplasms; Peptide Fragments; T-Lymphocytes; Telomerase | 2016 |
3 other study(ies) available for capecitabine and Delayed Hypersensitivity
| Article | Year |
|---|---|
Immediate and delayed hypersensitivity reactions to a single dose of oxaliplatin.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cecal Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Hypersensitivity, Delayed; Lymphatic Metastasis; Organoplatinum Compounds; Oxaliplatin; Prognosis | 2015 |
Successful Capecitabine Desensitization for a Delayed-Type Hypersensitivity Reaction.
Topics: Aged; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Desensitization, Immunologic; Drug Administration Schedule; Drug Eruptions; Humans; Hypersensitivity, Delayed; Immune Tolerance; Intradermal Tests; Male; Skin; Time Factors; Treatment Outcome | 2016 |
A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients.
Topics: Aged; Antibody Formation; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cancer Vaccines; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Dendritic Cells; Deoxycytidine; Fluorouracil; Humans; Hypersensitivity, Delayed; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Pilot Projects; T-Lymphocytes | 2010 |